LX3030 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

39 results for “LX3030”

Trials

View all 20 →

Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis

15 participants · First posted Feb 19, 2009

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

10 participants · First posted Nov 19, 2024

Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)

118 participants · First posted Mar 7, 2012

Drugs

View all 15 →

Investigational

LX1031

INDUS-83030

MDR-03030

News

Lexeo to Acquire Mantle Therapeutics for Up to $21.3M, Adding Four Frataxin-Targeting FA Programs

First Patient Dosed in Pioneering ZOLAR Trial of TLX300-CDx for Advanced Soft Tissue Sarcoma

Lexeo Therapeutics Reports Promising Phase I/II Data for Gene Therapy LX2020 in Rare Heart Disease

Page 1 of 4